WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Verneuil Vanina DeEVP and General Counsel2025-02-267,373$9.14
$67.40kSell
Backer Marianne DeChief Executive Officer2025-02-2416,122$9.45
$152.40kSell
George A. ScangosDirector2025-02-2410,056$9.45
$95.06kSell
Verneuil Vanina DeEVP and General Counsel2025-02-245,140$9.45
$48.59kSell
Ann M. HanlyEVP Chief Technology Officer2025-02-2414,168$9.45
$133.93kSell
Brent SabatiniSVP Chief Accounting Officer2025-02-241,562$9.45
$14.77kSell
George A. ScangosDirector2025-02-1810,964$9.81
$107.58kSell
Brent SabatiniSVP Chief Accounting Officer2025-02-131,562$9.15
$14.29kSell
Vicki L. SatoDirector2025-01-0810,960$12.52
$137.22kSell
Verneuil Vanina DeEVP and General Counsel2024-12-0276$8.22
$624.72Sell

1 of 2

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Endurance Cayman Ltd12.17%16,684,041$119.29MInsider
Sb Investment Advisers Uk Ltd12.17%16,684,041$119.29MInstitution
Alaska Permanent Fund Corp12.15%16,666,668$119.17MInsider
Blackrock Inc12.00%16,462,717$117.71MInstitution
Vanguard Group Inc9.57%13,130,635$93.88MInstitution
Temasek Holdings Private Ltd4.01%5,499,999$39.32MInsider
State Street Corp3.70%5,074,731$36.28MInstitution
Dhabi Investment Authority Abu2.67%3,666,666$26.22MInsider
Orbimed Advisors LLC2.35%3,218,617$23.01MInstitution
Melinda Gates Foundation Bill2.03%2,777,777$19.86MInsider

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR61.92%38.08%Net SellingNet Selling
RCUS59.71%40.29%Net BuyingNet Buying
NTLA71.84%28.16%Net SellingNet Selling
ELVN44.91%55.09%Net SellingNet Selling
RCKT59.61%40.39%Net SellingNet Selling
View Top Biotech Stocks

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 64.75% institutional shareholders, 39.82% Vir Biotechnology insiders, and 0.00% retail investors. Svf Endurance Cayman Ltd is the largest individual Vir Biotechnology shareholder, owning 16.68M shares representing 12.17% of the company. Svf Endurance Cayman Ltd's Vir Biotechnology shares are currently valued at $119.29M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.